Tumoricidal effects of β-glucans: Mechanisms include both antioxidant activity plus enhanced systemic and topical immunity

Nutrition and Cancer

Volumn 60, Issue 5, 2008, Pages 685-691

  Gu, YeunHwa ^a   Fujimiya, Yoshiaki ^b   Itokawa, Yuka ^a   Oshima, Masami ^a   Choi, Jung Sook ^c   Miura, Toshihiro ^a   Ishida, Torao ^a  

^a SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b Hachinohe University   (Japan)

^c GyeongDo Provincial College   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AGARICUS BLAZEI EXTRACT; BETA GLUCAN; CYTOKINE; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER GRAFT; CARCINOGENESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; EHRLICH ASCITES TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; IC 50; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPOTENTIATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PERITONEAL EXUDATE CELL; PERITONEUM LAVAGE; SARCOMA; TUMOR CELL DESTRUCTION; TUMOR IMMUNITY; TUMOR MODEL; TUMOR REGRESSION;

ADJUVANTS, IMMUNOLOGIC; AGARICUS; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BETA-GLUCANS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FREE RADICAL SCAVENGERS; MICE; MICE, INBRED ICR; TIME FACTORS;

AGARICUS BLAZEI; MURINAE; MUS;

EID: 51849086372     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580802030884     Document Type: Article

References (53)

1. Borchers AT, Keen CL, and Gershwin ME: Mushrooms, tumors, and immunity. Exp Biol Med 229, 393-406, 2004.
2. Wasser SP: Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 60, 258-274, 2002.
3. Fujimiya Y and Groveman DS: Effects of polysaccharides isolated from the Basidiomycetes or other natural medicinal plants on tumor regression and host immune response. In Recent Progress in Medicinal Plants, Globalization of Herbal Health, Vol. 12, Sharma AK, Singh VK, Govil JN, and Goyal NK (eds.). Houston, TX: Studium Press, 2006, pp. 87-98.
4. Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, et al.: Mechanisms by which orally administered β-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor model. J Immunol 173, 797-806, 2004.
5. Ohno N, Furukawa M, Miura NN, Adachi Y, Motoi M, et al.: Antitumor β-glucan from the cultured fruit body of Agaricus blazei. Biol Pharm Bull 24, 820-828, 2001.
6. Vetvicka V, Terayama K, Mandeville R, Brousseau P, Kournikakis B, et al.: Pilot study: orally-administered yeast β-1, 3-glucan prophylactically protects against anthrax infection and cancer in mice. JANA 5, 1-5, 2002.
7. Dillon S, Agrawal S, Banerjee K and Pulendran B: Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J Clin Invest 116, 916-928, 2006.
8. Ormandy LA, Farber A, Cantz T, Petrykowska S, Wedemeyer H, et al.: Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma. World J Gastroenterol 12, 3275-3282, 2006.
9. Thomas R and Lipsky PE: Dendritic cells: origin and differentiation. Stem Cells 14, 196-206, 1996.
10. Ahn WS, Kim DJ, Chae GT, Lee JM, Bae SM, et al.: Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy. Int J Gynecol Cancer 14, 589-594, 2004.
11. Duan X, Ackerly M, Vivier E, and Anderson P: Evidence for involvement of β-glucan-binding cell surface lectins in human natural killer cell function. Cell Immunol 157, 393-402, 1994.
12. Chihara G: Immunopharmacology of Lentinan, a polysaccharide isolated from Lentinus edodes: its applications as host defense potentiator. Int J Oriental Med 17, 55-57, 1992.
13. Ohno N, Adachi Y, Suzuki I, Oikawa S, Sato K, et al.: Antitumor activity of a β-1,3-glucan obtained from liquid culturedmycelium of Grifola frondosa. Biol Pharm Bull 9, 861-864, 1986.
14. Seljelid R: A water soluble animated β-1,3-D-glucan derivative causes regression of solid tumors in mice. Biosci Rep 6, 845-851, 1986.
15. Lee YL, Kim HJ, Lee MS, Kim JM, Han JS, et al.: Oral administration of Agaricus blazei (H1 strain) inhibited tumor growth in a sarcoma-180 inoculation model. Exp Anim 52, 371-375, 2003.
16. Oshiman K, Fujimiya Y, Ebina T, Suzuki I, and Noji M: Orally administered β-1,6-D-polyglucose extracted from Agaricus blazei results in tumor regression in tumor-bearing mice. Planta Med 68, 610-614, 2002.
17. Takaku T, Kimura Y, and Okuda H: Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action. J Nutr 131, 1409-1413, 2001.
18. Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, et al.: Clinical and biological effects of intraperitoneal injections of recombinant interferon-γ and recombinant interleukin-2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma. Clin Cancer Res 6, 2268-2278, 2000.
19. Fujimiya Y, Suzuki Y, Oshiman K, Kobori H, Moriguchi K, et al.: Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell activation and apoptosis. Cancer Immunol Immunother 46, 147-159, 1998.
20. Pan H, Yin C, and Van Dyke T: Apoptosis and cancer mechanisms. Cancer Surv 29, 305-327, 1997.
21. Naik P, Karrim J, and Hanahan D: The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev 10, 2105-2116, 1996.
22. Salganik RI, Albright CD, Rodgers J, Kim J, Zeisel SH, et al.: Dietary antioxidant depletion: enhancement of tumor apoptosis and inhibition of brain tumor growth in transgenic mice. Carcinogenesis 21, 909-914, 2000.
23. Guaiquil VH, Vera JC, and Golede DW: Mechanisms of vitamin C inhibition of cell death induced by oxidative stress in glutathione-depleted HL-60 cells. J Biol Chem 276, 40955-40961, 2001.
24. D'Andrea GM: Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin 55, 319-321, 2005.
25. Koleva II, Van Beek TA, Linssen JPH, de Groot A, and Evstatieva LN: Screening of plant extracts for antioxidant activity: a comparative study on three testing methods. Phytochem Anal 13, 8-17, 2002.
26. Orsolić N, Sver L, Terzić S, Tadić Z, and Basić I: Inhibitory effect of watersoluble derivative of Agaricus and its polyphenolic compounds on tumor growth and metastasizing ability: a possible mode of antitumor action. Nutr Cancer 47, 156-163, 2003.
27. Gach JE, Humphreys F, and Berth-Jones J: Randomized, double-blind, placebo-controlled pilot study to assess the value of free radical scavengers in reducing inflammation induced by cryotherapy. Clin Exp Dermatol 30, 14-16, 2005.
28. Rahmat A, Kumar V, Fong LM, Endrini S, and Sani HA: Determination of total antioxidant activity in three types of local vegetables shoots and the cytotoxic effect of their ethanolic extracts against different cancer cell lines. Asia Pac J Clin Nutr 12, 308-311, 2003.
29. Osawa T and Namiki M: A novel type of antioxidant isolated from leaf wax of Eucalyptus leaves. Agric Biol Chem 45, 735-739, 1981.
30. Gu YH, Takagi Y, Nakamura T, Hasegawa T, Suzuki I, et al.: Enhancement of radioprotection and anti-tumor immunity by yeast-derived β-glucan in mice. J Med Food 8, 154-158, 2005.
31. Suzuki I, Hayashi I, Takaki T, Groveman DS, and Fujimiya Y: Antitumor and anticytopenic effects of aqueous extracts of propolis in combination with chemotherapeutic agents. Cancer Biother Radiopharm 17, 553-562, 2002.
32. Mizutani A, Yamamoto H, and Suzuki I: Antitumor activity of Bovine Parotid Hypocalcemic substance obtained by Glacial Acetic Acid extraction. Gann 69, 291-297, 1978.
33. Tzianabos AO: Polysaccharide immunomodulators as therapeutic agents: Structural aspects and biological function. Clin Biol Rev 13, 523-533, 2000.
34. Clearly JA, Kelly GE, and Husband A: The effect of molecular weight and β-1,6-linkages on priming of macrophage function in mice by (1,3)-β-D-glucan. Immunol Cell Biol 77, 395-403, 1999.
35. Fujimiya Y, Yamamoto H, Noji M, and Suzuki I: Peroal effect on tumor progression of soluble β-(1, 6)-glucans prepared by acid treatment from Agaricus blazei Murr. (Agaricaceae, Higher Basidiomycetes). Int J Med Mushrooms 2, 43-49, 2000.
36. Sherwood ER, Williams DL, and Di Luzio NR: Glucan stimulates production of antitumor cytolytic/cytostatic factor(s) by macrophages. J Biol Response Modifiers 5, 504-526, 1986.
37. Browder W, Williams D, Pretus H, and Franchello A: Beneficial effect of enhanced macrophage function in the trauma patient. Ann Surg 211, 605-613, 1990.
38. Rasmussen LT and Seljelid R: Novel immunomodulators with pronounced in vivo effects caused by stimulation of cytokine release. J Cell Biochem 146, 60-68, 1991.
39. Philip R and Epstein LB: Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature 23, 86-89, 1986.
40. Drapier JC, Wietzerbin J, and Hibbs JB Jr: Interferon-γ and tumor necrosis factor induce the l-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol 18, 1587-1592, 1988.
41. Gonzalez A, Gregori W, Velez D, Restrepo A, and Cano LE: Nitric oxide participation in the fungicidal mechanism of γ interferon-activated murine macrophages against Paracoccidioides brasiliensis Conidia. Infect Immun 68, 2546-2552, 2000.
42. Smyth MJ, Kelly JM, Baxter AG, Körner H, and Sedgwick JD: An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum. J Exp Med 188, 1611-1619, 1998.
43. Finnberg N and El-Deiry WS: Selective TRAIL-induced apoptosis in dysplastic neoplasia of the colon may lead to new neoadjuvant and adjuvant therapies. Clin Cancer Res 12, 4132-4136, 2006.
44. Tsiapali E, Whaley S, Kalbfleisch J, Ensley HE, and Browder IW: Glucans exhibit weak antioxidant activity, but stimulate macrophage free radical activity. Free Radic Biol Med 30, 393-402, 2001.
45. Fullerton SA, Samadi AA, Tortorelis DG, Choudhury MS, Mallouh C, et al.: Induction of apoptosis in human prostatic cancer cells with β-glucan (maitake mushroom polysaccharide). Mol Urol 4, 7-13, 2000.
46. Lesperance ML, Olivotto IA, Forde N, Zhao Y, Speers C, et al.: Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study. Breast Cancer Res Treat 76, 137-143, 2002.
47. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, et al.: Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334, 1150-1155, 1996.
48. α-Tocopherol BCCPSG. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330, 1029-1035, 1994.
49. Li H, Kantoff PW, Giovannucci E, Leitzmann MF, Gaziano JM, et al.: Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res 65, 2498-2504, 2005.
50. Clark LC, Dalkin B, Krongrad A, Combs GF Jr., Turnbull BW, et al.: Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 81, 730-734, 1998.
51. Drisko JA, Chapman J, and Hunter VJ: The use of antioxidants with firstline chemotherapy in two cases of ovarian cancer. J Am Coll Nutr 22, 118-123, 2003.
52. Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, et al.: Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res 12, 4018-4026, 2006.
53. Miller ER III, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, et al.: Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142, 1-11, 2005.